The combination of ACTN3 (a gene influencing muscle fiber type) and menopause is not well studied. ACTN3 variants (R577X) affect the proportion of fast-twitch (type II) vs slow-twitch (type I) muscle fibers. During menopause, declining estrogen impacts muscle mass, bone density, and metabolism. Theoretically, women with the XX genotype (lacking α-actinin-3) may have lower power and sprint performance, potentially exacerbating age-related muscle loss. However, no specific human studies directly examine ACTN3–menopause interactions. Evidence is therefore unclear. Practical advice: all menopausal women should prioritize resistance training, adequate protein, and vitamin D – regardless of ACTN3 status. A DNA test alone does not provide actionable guidance for menopause. Be cautious of marketing claims linking ACTN3 to menopause symptoms. Consult a healthcare provider for personalized recommendations.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6c10edcc3bc4c99b6e45c4fe